About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5806238
Allelic
Composition
Lypd3tm1(KOMP)Vlcg/Lypd3tm1(KOMP)Vlcg
Genetic
Background
involves: C57BL/6J * C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Lypd3tm1(KOMP)Vlcg mutation (1 available); any Lypd3 mutation (22 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• at 52 weeks of age, females exhibit a significant reduction in total fat mass and are on average 9.7% less fat than wild-type controls
• both sexes are significantly lighter than wild-type and heterozygous littermates
• from 5 to 30 weeks of age, males are 5.8% lighter while females are 6.4% lighter than wild-type controls
• in females, the weight difference becomes significant at 2 weeks of age and increases to 15.9% from 30 to 50 weeks of age
• in males, the onset of the weight phenotype is delayed or the impact is less pronounced to reach significance at early time points
• at 52 weeks of age, the weight difference is primarily due to reduced fat deposition as both skeletal size (bone lengths) and bone mineral densities are normal

adipose tissue
• at 52 weeks of age, females show a significant reduction in subcutaneous fat relative to wild-type controls
• at 52 weeks of age, females show a significant reduction in abdominal fat relative to wild-type controls
• at 52 weeks of age, females exhibit a significant reduction in total fat mass and are on average 9.7% less fat than wild-type controls
• at 52 weeks of age, females exhibit a significant reduction in percent body fat/body weight relative to wild-type controls (21.6% vs 31.3%)

behavior/neurological
• at 12-14 weeks of age, females, but not males, show a modest (13.8%) decrease in food intake relative to wild-type controls

homeostasis/metabolism
• following prolonged exposure to N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) to induce malignant bladder carcinomas, fewer females develop invasive tumors relative to wild-type controls (44% vs 83%) primarily due to a decreased occurrence of early lesions invading into connective tissue (13% vs 39%) as opposed to later, more malignant lesions invading into the muscle layer (31% vs 44%)
• however, no significant differences are noted in the incidence of early hyperplastic lesions or in total tumor burden
• males, but not females, exhibit a modest but significant delay in skin wound healing kinetics relative to wild-type controls
• however, the histological appearance of incisional back skin wounds is normal at day 3, 7, 10 post-wounding and after healing at day 15

neoplasm
N
• following subcutaneous engraftment of Lewis Lung carcinoma cells, females show normal tumor take (100%) and tumor growth kinetics until day 12 post-injection relative to wild-type controls
• following prolonged exposure to N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) to induce malignant bladder carcinomas, fewer females develop invasive tumors relative to wild-type controls (44% vs 83%) primarily due to a decreased occurrence of early lesions invading into connective tissue (13% vs 39%) as opposed to later, more malignant lesions invading into the muscle layer (31% vs 44%)
• however, no significant differences are noted in the incidence of early hyperplastic lesions or in total tumor burden

integument
N
• surprisingly, at 52 weeks of age, females lack obvious histological epidermal phenotypes and show normal squamous epithelia morphology at various locations (including back skin, hair follicles, footpads, tongue, esophagus, non-glandular stomach, vagina and cornea) relative to wild-type controls
• TEM analysis of back skin from 10-week-old males showed no obvious membrane phenotypes at the subcellular level
• newborn pups show normal kinetics of trans-epidermal water loss (TEWL) relative to wild-type controls
• at 52 weeks of age, females show a significant reduction in subcutaneous fat relative to wild-type controls


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory